Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ibuprofen vs Dexamethasone for Post-Endodontic Pain
NCT06980870Phase 2Recruiting
- Sponsor
- Armed Forces Institute of Dentistry
- Start
- Feb 2025
- Primary completion
- Jun 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, open-label trial of ibuprofen and dexamethasone (2 arms), sponsored by Armed Forces Institute of Dentistry. Primary endpoint: Effect of pre-medication on post-endodontic pain at 24 hours. Started Feb 2025; status: recruiting.
02
Drugs
ibuprofendexamethasone
Beyond the preview
Go deeper on NCT06980870.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06980870.